Medtronic, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 121   

Articles published

MDT 73.87 +0.39 (0.53%)
price chart
EU Approves Medtronic's Merger With Covidien
BRUSSELS�Medical-device maker Medtronic Inc. secured European Union approval Friday for its $43 billion merger with rival Covidien PLC of Ireland, subject to conditions, two days after U.S.
Medtronic (MDT)-Covidien (COV) Deal Gets Green Light From FTC  Bidness ETC
Dividend Aristocrats In Focus Part 44: Medtronic (MDT)  Seeking Alpha
Related articles »  
Medtronic Acquisition of Covidien Receives US FTC Clearance
WASHINGTON�U. S. authorities on Wednesday approved Medtronic Inc. 's $43 billion merger with fellow medical device maker Covidien PLC after requiring the spinoff of a drug-coated catheter business.
Medtronic's acquisition of Covidien step closer to completion
�This regulatory clearance represents an important milestone in bringing our companies together,� Omar Ishrak, the Medtronic chief executive, said in a statement. Currently, only C.R. Bard Inc. of New Jersey has approval in the United States to sell ...
Medtronic gets US antitrust OK to buy Covidien with divestiture
The Federal Trade Commission said it would allow medical technology company Medtronic Inc's $42.9 billion deal to buy Dublin-based Covidien Plc on condition that it sell its drug-coated balloon catheter business.
Medtronic gets US antitrust approval to buy Covidien with divestiture
WASHINGTON Nov 26 (Reuters) - Medtronic Inc has won U.S. antitrust approval to buy Covidien PLC on condition that it sell its drug-coated balloon catheter business, the Federal Trade Commission said on Wednesday.
FTC OKs Medtronic-Covidien Deal on Asset Sale Clauses
Currently, Medtronic carries a Zacks Rank #3 (Hold). However, investors interested in the medical products industry can consider stocks like ICU Medical, Inc. (ICUI - Snapshot Report) and OraSure Technologies, Inc. (OSUR - Snapshot Report), both with a ...
Medtronic profit meets expectations; Covidien deal on track
Nov 18 (Reuters) - Medtronic Inc posted a quarterly profit that was in line with analyst expectations, helped by sales of new heart devices, and said its $42.9 billion purchase of hospital products maker Covidien Plc remains on track to close early ...
See Why Medtronic Stock Is Surging Today  Seeking Alpha (registration)
Medtronic Sales Rise, Backs Covidien Deal  Wall Street Journal
Related articles »  
Medtronic, Covidien deal gets anti-trust OK
Anti-trust regulators have approved medical-device maker Medtronic Inc.'s $43 billion deal to buy Covidien. The Federal Trade Commission required Ireland-based Covidien to sell off its drug-coated balloon business as part of a settlement announced ...
Covidien, Medtronic Shareholders Poised for January Vote
Medtronic CFO Gary Ellis would not give a specific prediction of when the deal would close during the company's second quarter earnings call Nov. 18, but told analysts that setting of the shareholder votes was a good indication that company officials ...
Related articles »  
Medtronic deal to spur charitable giving
The pain felt by many longtime Medtronic Inc. shareholders is turning into a big gain for their favorite charities. Longtime holders of stock in Fridley's medical technology giant were stunned to learn earlier this year that they'll face potentially ...